Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.
Nat Med. 2019 Mar;25(3):454-461. doi: 10.1038/s41591-019-0357-y. Epub 2019 Feb 25.
Nat Med. 2019.
PMID: 30804515
Free PMC article.
Clinical Trial.
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells.
Wang K, Coutifaris P, Brocks D, Wang G, Azar T, Solis S, Nandi A, Anderson S, Han N, Manne S, Kiner E, Sachar C, Lucas M, George S, Yan PK, Kier MW, Laughlin AI, Kothari S, Giles J, Mathew D, Ghinnagow R, Alanio C, Flowers A, Xu W, Tenney DJ, Xu X, Amaravadi RK, Karakousis GC, Schuchter LM, Buggert M, Oldridge D, Minn AJ, Blank C, Weber JS, Mitchell TC, Farwell MD, Herati RS, Huang AC.
Wang K, et al. Among authors: kier mw.
Cancer Cell. 2024 Sep 9;42(9):1582-1597.e10. doi: 10.1016/j.ccell.2024.08.007. Epub 2024 Aug 29.
Cancer Cell. 2024.
PMID: 39214097
Item in Clipboard
If You Book It, Will They Come? Attendance at Postdischarge Follow-Up Visits Scheduled by Inpatient Providers.
Banerjee R, Suarez A, Kier M, Honeywell S, Feng W, Mitra N, Grande D, Myers J.
Banerjee R, et al.
J Hosp Med. 2017 Aug;12(8):618-625. doi: 10.12788/jhm.2777.
J Hosp Med. 2017.
PMID: 28786427
Item in Clipboard
Correlation of the Ki67 Working Group prognostic risk categories with the Oncotype DX Recurrence Score in early breast cancer.
Patel R, Hovstadius M, Kier MW, Moshier EL, Zimmerman BS, Cascetta K, Jaffer S, Sparano JA, Tiersten A.
Patel R, et al. Among authors: kier mw.
Cancer. 2022 Oct;128(20):3602-3609. doi: 10.1002/cncr.34426. Epub 2022 Aug 10.
Cancer. 2022.
PMID: 35947048
Free PMC article.
Item in Clipboard
Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS).
Casasanta N, Patel R, Raymond S, Kier MW, Blanter J, Sohval S, Hovstadius M, Wu C, Zimmerman B, Cascetta K, Bagiella E, Tiersten A.
Casasanta N, et al. Among authors: kier mw.
Clin Breast Cancer. 2024 Oct;24(7):585-596. doi: 10.1016/j.clbc.2024.06.005. Epub 2024 Jun 12.
Clin Breast Cancer. 2024.
PMID: 38971641
Item in Clipboard
Cite
Cite